These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33865876)

  • 1. Prior transient exposure to interleukin-21 delivered by recombinant adeno-associated virus vector protects mice from hepatitis B virus persistence.
    Shen Z; Gao Z; Gu C; Wu J; Wang J; Zhang J; Xie Y; Liu J
    Antiviral Res; 2021 Jun; 190():105076. PubMed ID: 33865876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.
    Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y
    Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-33 mediates both immune-related and non-immune-related inhibitory effects against hepatitis B virus.
    Gao Z; Shen Z; Wu J; Song Y; Liu N; Deng Q; Xie Y; Liu J
    Antiviral Res; 2022 Oct; 206():105404. PubMed ID: 36049553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
    Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.
    Zou S; Du Y; Huang S; Chen M; Yang X; Li S; Chen Y; Han M; Li J; Yu Q; Littwitz-Salomon E; Huang H; Trilling M; Liu S; Pei R; Liu J; Wang B; Zheng X; Lu M; Dittmer U; Sun S; Yang D; Wu J
    J Virol; 2021 Nov; 95(24):e0003421. PubMed ID: 34550772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8
    Chiale C; Moshkani S; Rose JK; Robek MD
    Antiviral Res; 2019 Aug; 168():156-167. PubMed ID: 31153968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance.
    Shen Z; Yang H; Yang S; Wang W; Cui X; Zhou X; Liu W; Pan S; Liu Y; Zhang J; Zhang J; Xie Y; Liu J
    Nat Commun; 2017 Dec; 8(1):2119. PubMed ID: 29242561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia.
    Wu M; Wang C; Shi B; Fang Z; Qin B; Zhou X; Zhang X; Yuan Z
    Antiviral Res; 2020 Aug; 180():104826. PubMed ID: 32502604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection.
    Shen Z; Wu J; Gao Z; Wang J; Zhu H; Mao R; Wang X; Zhang J; Xie Y; Liu J
    Theranostics; 2020; 10(12):5600-5612. PubMed ID: 32373234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
    Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
    Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
    Zhu W; Wu C; Deng W; Pei R; Wang Y; Cao L; Qin B; Lu M; Chen X
    PLoS One; 2012; 7(9):e45146. PubMed ID: 23024803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
    Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
    Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection.
    Chuai X; Wang W; Chen H; Deng Y; Wen B; Tan W
    Antiviral Res; 2014 Jan; 101():68-74. PubMed ID: 24239872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector.
    Lucifora J; Salvetti A; Marniquet X; Mailly L; Testoni B; Fusil F; Inchauspé A; Michelet M; Michel ML; Levrero M; Cortez P; Baumert TF; Cosset FL; Challier C; Zoulim F; Durantel D
    Antiviral Res; 2017 Sep; 145():14-19. PubMed ID: 28709657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
    Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
    Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
    Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.
    Ko C; Su J; Festag J; Bester R; Kosinska AD; Protzer U
    Antiviral Res; 2021 Oct; 194():105140. PubMed ID: 34284057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.
    Qi Z; Li G; Hu H; Yang C; Zhang X; Leng Q; Xie Y; Yu D; Zhang X; Gao Y; Lan K; Deng Q
    J Virol; 2014 Jul; 88(14):8045-56. PubMed ID: 24807718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.
    Tzeng HT; Tsai HF; Liao HJ; Lin YJ; Chen L; Chen PJ; Hsu PN
    PLoS One; 2012; 7(6):e39179. PubMed ID: 22761734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.